AI In Bioinformatics Market Anticipated to Undergo Strong Growth Through 2029

 Claim 20% Off With Code ONLINE20 — Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

 

 How Is the AI In Bioinformatics Market Growth Forecast from 2025 to 2029?
 The AI in bioinformatics market size has grown exponentially in recent years. It will grow from $4.3 billion in 2024 to $6.14 billion in 2025 at a compound annual growth rate (CAGR) of 42.9%. The growth in the historic period can be attributed to increased genomic data availability, rise of precision medicine, demand for biomarker discovery, clinical trial optimization, and increased collaboration.
 
 The AI in bioinformatics market size is expected to see exponential growth in the next few years. It will grow to $26.15 billion in 2029 at a compound annual growth rate (CAGR) of 43.7%. The growth in the forecast period can be attributed to expansion of single-cell technologies, growing emphasis on multi-omics integration, rising focus on functional genomics, acceleration of drug repurposing, increasing adoption of AI in pathology. Major trends in the forecast period include ethical AI and responsible data use, AI-driven virtual laboratories, integration of quantum computing, AI-powered clinical trials, and blockchain for secure data sharing.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp
 
 What Are the Key Growth Factors Supporting the AI In Bioinformatics Market Expansion?
 The increasing number of clinical trials is expected to propel the growth of AI in the bioinformatics market going forward. Clinical trials refer to a systematic and carefully designed process of conducting medical research involving human participants to evaluate the safety, efficacy, and effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. AI in bioinformatics is used in clinical trials to analyze patient data from electronic health records and other sources to identify potential candidates for clinical trials who meet specific criteria, improving recruitment efficiency and targeting. For instance, in May 2023, according to Xtalks, a Canada-based life science and medical device platform, on ClinicalTrials.gov, there were 452,604 clinical trials registered worldwide as of May 2023, and 64,838 of the total number of registered studies are actively seeking participants. Further, the number of registered trials has significantly increased from the over 365,000 that were reported at the beginning of 2021. Therefore, the increasing number of clinical trials is driving the growth of AI in the bioinformatics market.
 
 What Segments Are Covered in the AI In Bioinformatics Market Report?
 The ai in bioinformatics market covered in this report is segmented — 
 
 1) By Type: Machine Learning, Deep Learning, Other Types
 2) By Offering: Services, Software
 3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications
 
 Subsegments:
 1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms, Reinforcement Learning 
 2) By Deep Learning: Neural Networks, Natural Language Processing Models, Generative Adversarial Networks (GANs) 
 3) By Other Types: Statistical Models, Evolutionary Algorithms, Fuzzy Logic Systems
 
 How Are Current Trends Influencing the AI In Bioinformatics Market Growth?
 Major companies operating in the AI in bioinformatics market are innovating technological advancements on the Bionl.AI platform to increase their profitability in the market. Bionl.AI offers an all-in-one workspace for exploration, analysis, and visualization, cutting down the time required to complete complicated tasks from days to minutes. For instance, in October 2023, Bionl Inc., a US-based biomedical and bioinformatics research platform company, launched Bionl.AI, a pioneering platform that aims to revolutionize biomedical and bioinformatics research by providing a no-code solution for researchers, students, and professionals to investigate biomedicine using natural language queries. The platform leverages state-of-the-art GenAI models to enable instant insights and make complex analysis accessible and engaging.
 
 Who Are the Key Players Driving the AI In Bioinformatics Market?
 Major companies operating in the AI in bioinformatics market report are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Illumina Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., SourceBio International Limited, Fios Genomics Limited, CelbridgeScience, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.
 
 Get the full ai in bioinformatics market report here:
 https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report
 
 How Does AI In Bioinformatics Market Growth Vary Across Major Regions?
 North America was the largest region in the AI in bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company